[go: up one dir, main page]

PE20081799A1 - Mejoras en composiciones medicinales o relativas a las mismas - Google Patents

Mejoras en composiciones medicinales o relativas a las mismas

Info

Publication number
PE20081799A1
PE20081799A1 PE2008000410A PE2008000410A PE20081799A1 PE 20081799 A1 PE20081799 A1 PE 20081799A1 PE 2008000410 A PE2008000410 A PE 2008000410A PE 2008000410 A PE2008000410 A PE 2008000410A PE 20081799 A1 PE20081799 A1 PE 20081799A1
Authority
PE
Peru
Prior art keywords
medicinal compositions
buprenorphine
dosage form
unit dosage
naltrexone
Prior art date
Application number
PE2008000410A
Other languages
English (en)
Inventor
Christopher Bourne Chapleo
Neil Hyde
Original Assignee
Reckitt Benckiser Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37965733&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20081799(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Reckitt Benckiser Healthcare filed Critical Reckitt Benckiser Healthcare
Publication of PE20081799A1 publication Critical patent/PE20081799A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA EN UNA FORMA DE DOSIFICACION PARENTERAL UNITARIA O EN UNA FORMA DE DOSIFICACION UNITARIA ADECUADA PARA UNA ADMINISTRACION POR LA MUCOSA O LA DERMIS QUE COMPRENDE: A) BUPRENORFINA QUE SE ENCUENTRA EN UNA CANTIDAD ENTRE 10 G Y 8MG; Y B) NALTREXONA, EN DONDE LA RELACION EN PESO DE BUPRENORFINA A NALTREXONA ADMINISTRADA O QUE ALCANZO EL PLASMA DE UN PACIENTE SE ENCUENTRA EN EL RANGO ENTRE 100:1 Y 5000:1. DICHA COMPOSICION ES UTIL EN EL TRATAMIENTO DEL DOLOR
PE2008000410A 2007-03-01 2008-02-29 Mejoras en composiciones medicinales o relativas a las mismas PE20081799A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0703966A GB2447014A (en) 2007-03-01 2007-03-01 Analgesic composition comprising a specific ratio of buprenorphine and naltrexone

Publications (1)

Publication Number Publication Date
PE20081799A1 true PE20081799A1 (es) 2008-12-18

Family

ID=37965733

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000410A PE20081799A1 (es) 2007-03-01 2008-02-29 Mejoras en composiciones medicinales o relativas a las mismas

Country Status (21)

Country Link
US (1) US8912211B2 (es)
EP (1) EP2125019B1 (es)
JP (1) JP5577101B2 (es)
KR (1) KR20090115861A (es)
CN (1) CN101622014A (es)
AR (1) AR065580A1 (es)
AU (1) AU2008220620A1 (es)
BR (1) BRPI0807902A2 (es)
CA (1) CA2678481C (es)
CL (1) CL2008000608A1 (es)
DK (1) DK2125019T3 (es)
ES (1) ES2475734T3 (es)
GB (1) GB2447014A (es)
HR (1) HRP20140592T1 (es)
MX (1) MX2009009132A (es)
PE (1) PE20081799A1 (es)
PL (1) PL2125019T3 (es)
PT (1) PT2125019E (es)
TW (1) TW200836737A (es)
WO (1) WO2008104735A1 (es)
ZA (1) ZA200905689B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9095548B2 (en) 2010-04-29 2015-08-04 Allodynic Therapeutics, Llc Combinations of opioid/TLR4 antagonists and acetyl-para-aminophenol (APAP) for use in the treatment of pain
US9205081B2 (en) 2010-04-29 2015-12-08 Allodynic Therapeutics, Llc Combinations of opiod/TLR4 antagonist and a cyclooxygenase (COX) inhibitor for use in the treatment of pain
MX2013003354A (es) * 2010-09-21 2013-06-24 Purdue Pharma Lp Analogos de buprenorfina.
WO2014160077A1 (en) * 2013-03-13 2014-10-02 Allodynic Therapeutics, Llc Compositions to reduce pain comprising an opioid/toll-like receptor 4 antagonist, dextro enantiomers thereof, and methods of use therefor
EP3013344B1 (en) * 2013-06-28 2018-10-24 Purdue Pharma L.P. Opioid antagonists for use in the treatment of an opioid analgesic-induced arrhythmia
US9839611B2 (en) 2013-09-10 2017-12-12 Insys Development Company, Inc. Sublingual buprenorphine spray
US9918981B2 (en) 2013-09-10 2018-03-20 Insys Development Company, Inc. Liquid buprenorphine formulations
US9867818B2 (en) 2013-09-10 2018-01-16 Insys Development Company, Inc. Sublingual buprenorphine spray
US9216175B2 (en) 2013-09-10 2015-12-22 Insys Pharma, Inc. Sublingual buprenorphine spray
US9642848B2 (en) 2014-07-08 2017-05-09 Insys Development Company, Inc. Sublingual naloxone spray
US10722510B2 (en) 2014-07-08 2020-07-28 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
US10617686B2 (en) 2014-07-08 2020-04-14 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
US20180147201A1 (en) 2016-10-31 2018-05-31 Allodynic Therapeutics, Llc Combinations of opioid/tlr4 antagonists and acetaminophen for use in the treatment of emotional pain and insomnia
US12343340B2 (en) 2020-12-31 2025-07-01 Soin Therapeutics Llc Methods of using low dose naltrexone to treat chronic pain
US11752143B2 (en) 2020-12-31 2023-09-12 Soin Therapeutics Llc Methods of using low dose naltrexone to treat chronic pain

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US572149A (en) * 1896-12-01 Tobacco-cutting machine
GB8430346D0 (en) 1984-11-30 1985-01-09 Reckitt & Colmann Prod Ltd Analgesic compositions
GB8728294D0 (en) * 1987-12-03 1988-01-06 Reckitt & Colmann Prod Ltd Treatment compositions
US5272149A (en) * 1992-05-05 1993-12-21 Stalling Reginald W Symptom controlled receptor substitution for addiction withdrawl
US6096756A (en) * 1992-09-21 2000-08-01 Albert Einstein College Of Medicine Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
AU755790B2 (en) * 1997-12-22 2002-12-19 Euro-Celtique S.A. A method of preventing abuse of opioid dosage forms
AR031682A1 (es) 1999-11-19 2003-10-01 Reckitt Benckiser Helthcare Uk Composiciones farmaceuticas
PT2092936E (pt) * 2000-02-08 2013-06-20 Euro Celtique Sa Formulações orais de agonistas de opióides resistentes a adulteração
US20050191340A1 (en) * 2002-08-09 2005-09-01 Gruenenthal Gmbh Opioid-receptor antagonists in transdermal systems having buprenorphine

Also Published As

Publication number Publication date
AR065580A1 (es) 2009-06-17
GB0703966D0 (en) 2007-04-11
EP2125019B1 (en) 2014-04-09
CA2678481A1 (en) 2008-09-04
ZA200905689B (en) 2010-10-27
US20100120812A1 (en) 2010-05-13
CN101622014A (zh) 2010-01-06
DK2125019T3 (da) 2014-06-30
JP2010520183A (ja) 2010-06-10
WO2008104735A1 (en) 2008-09-04
ES2475734T3 (es) 2014-07-11
AU2008220620A1 (en) 2008-09-04
MX2009009132A (es) 2009-09-03
HRP20140592T1 (hr) 2014-09-12
PL2125019T3 (pl) 2014-08-29
PT2125019E (pt) 2014-07-11
CL2008000608A1 (es) 2008-10-03
CA2678481C (en) 2014-11-18
EP2125019A1 (en) 2009-12-02
TW200836737A (en) 2008-09-16
BRPI0807902A2 (pt) 2014-06-17
US8912211B2 (en) 2014-12-16
JP5577101B2 (ja) 2014-08-20
GB2447014A (en) 2008-09-03
KR20090115861A (ko) 2009-11-09

Similar Documents

Publication Publication Date Title
PE20081799A1 (es) Mejoras en composiciones medicinales o relativas a las mismas
AR065579A1 (es) Mejoras en composiciones medicinales o relativas a las mismas
AR065581A1 (es) Mejoras en composiciones medicinales o relativas a las mismas
AR075735A1 (es) Composiciones farmaceuticas de liberacion inmediata que comprenden oxicodona y naloxona. uso
NZ605887A (en) Pharmaceutical dosage form comprising 6’-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4’,9’-dihydro-3’h-spiro[cyclohexane-1,1’-pyrano[3,4,b]indol]-4-amine for the treatment of neuropathic pain
AR031682A1 (es) Composiciones farmaceuticas
EA201690102A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
EA201290171A1 (ru) Вводимые перорально кортикостероидные композиции
AR065582A1 (es) Mejoras en composiciones medicinales o relativas a las mismas
GT200100211AA (es) Compuestros de imidazol condensado con arilo o heteroarilo como agentes anti-inflamatorios y analgesicos. (patentefraccionaria no. 1 de la solicitud de patente de invencion no. pi-2001-0211.
GT200600445A (es) Formas de presentación farmaceuticas solidas de administración oral con liberacion rapida del principio activo.
NZ587202A (en) Methods for measuring a patient response upon administration of a drug and compositions thereof
CL2011002858A1 (es) Uso de una composicion farmaceutica transmucosa oral que comprende dexmedetomidina y una sal farmaceuticamente aceptable y un excipiente farmaceuticamente aceptable para preparar un medicamento util para tratar o prevenir el dolor.
WO2012007159A3 (en) Novel gastro-retentive dosage forms
AR065731A1 (es) Composiciones farmaceuticas que contienen 2-[6-(3-amino-pipenidin-1-il)-3-metil-2,4-dioxo-3,4-dihidro-2h-primidin-1-il metil]-4-fluoro-benzonitrilo. uso. metodo de tratamiento, administracion semanal de inhibidores de la dipeptidilpeptidasa.
BR102013003570A8 (pt) Composições de plasma rico em plaquetas
IL196425A0 (en) Pharmaceutical compositions containing ibuprofen and famotidine
HRP20192189T1 (hr) Doziranja i terapijske primjene l-4-klorokinurenina
AR072951A1 (es) Uso de dronedarona o una sal aceptable farmaceuticamente de esta, para la preparacion de un medicamento para regular el nivel de potasio en la sangre
JP2010520184A5 (es)
AR065139A1 (es) Medicamento para el tratamiento de la endometriosis
CL2010001577A1 (es) Uso de nifurtimox para preparar un medicamento util en el tratamiento de enfermedades causadas por giardias.
RU2013105513A (ru) Производные 1-аминоалкилциклогексана для лечения воспалительных заболеваний кожи
ATE466574T1 (de) Verfahren und zusammensetzungen zur oralen fts- abgabe
NZ604009A (en) A combination composition comprising ibuprofen and paracetamol

Legal Events

Date Code Title Description
FC Refusal